Safety In Bristol Myers' New Brunswick Neighborhood

Bristol Myers Squibb's New Brunswick site has been recognised as a leader in the Governor's Occupational Safety and Health Awards programme for over 20 years. The company also provides access to its facilities for training operations for police K-9 teams and hands-on fire extinguisher training for local fire departments and associated agencies.

The New Brunswick facility has been in continuous operation since 1905, when E.R. Squibb & Sons relocated operations from Brooklyn, New York. It has evolved from a manufacturing site to a Research & Development facility, with over 40 buildings totalling 1.8–1.9 million square feet on 96–105 acres.

The site focuses on product and process development and manufacturing to support clinical trials. It is also home to the Bristol Myers Squibb Children's Hospital, which is affiliated with Robert Wood Johnson University Hospital and is one of the state's largest and most comprehensive children's hospitals.

The area has a freestanding, 68-bed paediatric acute care children's hospital

The area around Bristol-Myers, New Brunswick, is served by the Bristol Royal Hospital for Children, which is a freestanding, 68-bed paediatric acute care children's hospital. The hospital is part of the University Hospitals Bristol and Weston NHS Foundation Trust, which was formed in 2020 through the merger of University Hospitals Bristol NHS Foundation Trust and Weston Area Health NHS Trust.

The Bristol Royal Hospital for Children offers a range of services, including paediatric respiratory medicine and a paediatric emergency department. The hospital is dedicated to providing specialised care for children and young people in the region. It works closely with other healthcare providers in the area to ensure the safe transfer of critically ill children, coordinating with local clinicians to determine the best ongoing care options.

The hospital is committed to patient safety and experience, providing support and guidance for patients and their families. It also recognises the importance of research and innovation, with various resources available on its website for patients, visitors, and researchers.

In addition to the hospital's efforts, the Bristol City Council has been working with the Centre of Expertise on child sexual abuse to develop a tool that highlights good practices when there are concerns about a child's safety and well-being. This tool aims to provide clarity on professionals' responsibilities and actions, ensuring that children in Bristol receive the support and protection they need.

Furthermore, paediatricians in New Brunswick have been advocating for stricter safety regulations for youth-sized all-terrain vehicles (ATVs). They have expressed concerns about the lack of government oversight and evaluation of these vehicles, which are marketed as safe for children. Canadian paediatricians, including Dr Mike Dickinson, have been calling for stricter standards and enforcement to ensure the health and safety of children.

Bristol Myers Squibb supports community health programs to improve health

Bristol Myers Squibb (BMS) is committed to supporting community health programs and improving health outcomes for underserved populations. The company's focus on community development and health equity is evident through its various initiatives and partnerships.

The BMS Foundation plays a crucial role in advancing health equity and improving access to quality healthcare for underserved communities worldwide. Through collaboration with government, nonprofit, academic, and private sector partners, the foundation addresses health disparities and strengthens health systems. This includes providing support for programs that offer specialty care services for vulnerable populations, such as those with cancer, HIV, autoimmune diseases, and cardiovascular diseases. BMS also recognizes the importance of diversity in clinical trials, aiming to enhance the development of therapeutics for all populations.

In New Brunswick, New Jersey, BMS has been actively involved in community initiatives. The company supported the establishment of the Bristol Myers Squibb Children's Hospital, which is now one of the state's largest and most comprehensive children's hospitals. BMS has also contributed to the creation of pediatric specialty centers, focusing on urgent health challenges such as childhood obesity, infectious diseases, and rheumatic disease.

Additionally, BMS supports community health programs targeting African American women, helping them understand the risks of cardiovascular disease and empowering them to take positive steps towards better health. They also collaborate with the Civic League of Greater New Brunswick on the Georges Road Gateway Project, which includes initiatives to improve pedestrian safety, enhance science and math education, and redevelop community spaces.

BMS's commitment to education is evident through its donations to the New Brunswick Education Foundation, introducing engineering, robotics, biotechnology, and environmental science to students. They also support the School-Based Youth Services Program, providing mental health treatment and comprehensive services to help vulnerable children succeed in school.

Furthermore, BMS has a strong presence in nearby Lawrenceville, New Jersey, where their campus serves as an early discovery site for cancer, immunology, cardiovascular, and fibrotic disease research. The company's presence in the region contributes to its ability to support and engage with local communities, fostering a culture of health and well-being.

The site has been recognised as a leader in the Governor's Occupational Safety and Health Awards

The New Brunswick site of Bristol Myers Squibb has been recognised as a leader in the Governor's Occupational Safety and Health Awards program for over 20 years. The health and safety of its employees are among the company's top priorities, with a long-term aspiration to eliminate work-related injuries and illnesses.

Bristol Myers Squibb has implemented an Environmental, Health & Safety Management (EHS) System framework that details program requirements focused on compliance, training, and continuous improvement. All sites are required to conduct EHS program self-assessments and are subject to periodic corporate EHS audits based on facility size, functionality, and risk. Additionally, the company has established a comprehensive Occupational Health and Safety Standards Manual that outlines requirements and guiding principles for its global network of facilities.

To further enhance safety, all Bristol Myers Squibb sites must have a self-inspection program where potential hazards are proactively identified and remediated. The company also maintains site-wide and/or departmental safety committees where employees collaborate to address safety concerns.

In addition to its internal initiatives, Bristol Myers Squibb actively contributes to the safety of the wider community. It provides access to its facilities for training operations for police K-9 teams and local fire departments, including hands-on fire extinguisher training. The company also offers Confined Space Rescue Training for emergency responders in Mercer and Middlesex counties, and its employees participate in the Mercer County Technical Rescue Operations Team.

The company has donated to the New Brunswick Education Foundation

The area around Bristol Myers in New Brunswick, New Jersey, is a safe and thriving community, thanks in part to the company's contributions to various local initiatives and organizations. The company has been in operation in the area since 1905 and has shown a strong commitment to supporting the well-being and development of the local community.

One notable example of Bristol Myers' contributions is their support for the New Brunswick Education Foundation. The company has donated to the foundation, helping to enhance the educational opportunities available to local students. With these donations, the New Brunswick Public Schools have been able to introduce engineering and robotics to middle school students and bring engineering, biotechnology, and environmental science to elementary students.

The impact of Bristol Myers' donations to the New Brunswick Education Foundation has been significant. For instance, the donations have enabled New Brunswick High School to purchase musical instruments and restore its student orchestra after a 20-year hiatus. This not only fosters musical talent and appreciation among students but also provides a creative outlet and a source of joy for the school community.

In addition to their support for the New Brunswick Education Foundation, Bristol Myers has also been actively involved in other community initiatives. They have partnered with local hospitals, such as the Robert Wood Johnson University Hospital, to establish and enhance children's healthcare services. The company has also supported community health programs aimed at improving health outcomes for African American women, particularly regarding cardiovascular disease.

Furthermore, Bristol Myers has demonstrated a commitment to improving the overall safety and well-being of the community. They have supported the Civic League of Greater New Brunswick's Georges Road Gateway Project, which includes initiatives to improve pedestrian safety and redevelop local parks. The company also provides training opportunities for emergency responders and access to their facilities for training operations for police K-9 teams and local fire departments.

Overall, Bristol Myers' donations to the New Brunswick Education Foundation and their involvement in various community initiatives contribute to the safety and well-being of the area. Their support for education, healthcare, and community development reflects a responsible and thoughtful approach to corporate citizenship.

The New Brunswick site focuses on product and process development

The New Brunswick site of Bristol Myers Squibb has been in operation since 1905. Over the years, the site's focus has shifted from manufacturing to research and development. The campus, which spans over 96 acres, houses more than 40 buildings, totalling over 1.8 million square feet of space. The site is primarily dedicated to product and process development, as well as manufacturing support for clinical trials.

The New Brunswick facility plays a crucial role in the company's research and development endeavours. Scientists and researchers at this site work tirelessly to discover and develop innovative medicines and treatments. The site's state-of-the-art laboratories and research facilities enable them to explore new frontiers in various therapeutic areas, including cancer, immunology, cardiovascular diseases, and fibrotic diseases.

The New Brunswick site exemplifies Bristol Myers Squibb's commitment to staying at the forefront of scientific advancements. By investing in research and development, the company ensures that it remains a leader in the pharmaceutical industry, consistently ranking among the largest US corporations on the Fortune 500 list. The site's large footprint and extensive resources reflect the company's dedication to bringing life-changing treatments to patients.

In addition to its focus on product and process development, the New Brunswick site also actively engages in sustainability initiatives. As the largest site within the Bristol Myers Squibb Corporation, it consumes significant energy and water resources. To address this, the site has established cross-functional teams that work on improvement projects and employee engagement initiatives. These teams collaborate with regional groups to review data, share ideas, and implement energy- and water-efficient solutions.

The New Brunswick site's commitment to sustainability is evident in their infrastructure efficiency projects. They have implemented improved water treatment control systems, optimised their chilled water plants, and made lighting changes to reduce their carbon footprint. Additionally, they actively reuse treated water, demonstrating their dedication to environmental stewardship.

Frequently asked questions